APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acute Hyperammonemia Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acute Hyperammonemia Treatment Drugs Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchAcute Hyperammonemia Treatment Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Hyperammonemia Treatment Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Acute Hyperammonemia Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Hyperammonemia Treatment Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Hyperammonemia Treatment Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Acute Hyperammonemia Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Acute Hyperammonemia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acute Hyperammonemia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acute Hyperammonemia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acute Hyperammonemia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Acute Hyperammonemia Treatment Drugs include Abbott Laboratories, Lee's Pharmaceutical, Amgen, Ultragenyx Pharmaceutical, Spyre Therapeutics, Sigmapharm Laboratories, Selecta Biosciences, Recordati and Orpharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Acute Hyperammonemia Treatment Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acute Hyperammonemia Treatment Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Acute Hyperammonemia Treatment Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acute Hyperammonemia Treatment Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acute Hyperammonemia Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Acute Hyperammonemia Treatment Drugs sales, projected growth trends, production technology, application and end-user industry.

Acute Hyperammonemia Treatment Drugs Segment by Company

Abbott Laboratories

Lee's Pharmaceutical

Amgen

Ultragenyx Pharmaceutical

Spyre Therapeutics

Sigmapharm Laboratories

Selecta Biosciences

Recordati

Orpharma

Medunik

Immedica

Arcturus Therapeutics

Acer Therapeutics

Acute Hyperammonemia Treatment Drugs Segment by Type

Sodium Phenylbutyrate

Sodium Benzoate

Arginine

Other

Acute Hyperammonemia Treatment Drugs Segment by Application

Hospital

Clinic

Acute Hyperammonemia Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Hyperammonemia Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Hyperammonemia Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Hyperammonemia Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Acute Hyperammonemia Treatment Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Acute Hyperammonemia Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Hyperammonemia Treatment Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acute Hyperammonemia Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sodium Phenylbutyrate Major Manufacturers Table 3. Sodium Benzoate Major Manufacturers Table 4. Arginine Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Acute Hyperammonemia Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Acute Hyperammonemia Treatment Drugs Industry Trends Table 10. Acute Hyperammonemia Treatment Drugs Industry Drivers Table 11. Acute Hyperammonemia Treatment Drugs Industry Opportunities and Challenges Table 12. Acute Hyperammonemia Treatment Drugs Industry Restraints Table 13. Global Acute Hyperammonemia Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Acute Hyperammonemia Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Acute Hyperammonemia Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Acute Hyperammonemia Treatment Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Acute Hyperammonemia Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Acute Hyperammonemia Treatment Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2021-2026) Table 22. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2027-2032) Table 23. Global Acute Hyperammonemia Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Acute Hyperammonemia Treatment Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Acute Hyperammonemia Treatment Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Acute Hyperammonemia Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Acute Hyperammonemia Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Acute Hyperammonemia Treatment Drugs Manufacturers, Product Type & Application Table 31. Global Acute Hyperammonemia Treatment Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Acute Hyperammonemia Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Acute Hyperammonemia Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Acute Hyperammonemia Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2021-2026) Table 43. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2027-2032) Table 44. Global Acute Hyperammonemia Treatment Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Acute Hyperammonemia Treatment Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Acute Hyperammonemia Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Acute Hyperammonemia Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2021-2026) Table 55. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2027-2032) Table 56. Global Acute Hyperammonemia Treatment Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Acute Hyperammonemia Treatment Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Abbott Laboratories Company Information Table 59. Abbott Laboratories Business Overview Table 60. Abbott Laboratories Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Abbott Laboratories Acute Hyperammonemia Treatment Drugs Product Portfolio Table 62. Abbott Laboratories Recent Development Table 63. Lee's Pharmaceutical Company Information Table 64. Lee's Pharmaceutical Business Overview Table 65. Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Product Portfolio Table 67. Lee's Pharmaceutical Recent Development Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amgen Acute Hyperammonemia Treatment Drugs Product Portfolio Table 72. Amgen Recent Development Table 73. Ultragenyx Pharmaceutical Company Information Table 74. Ultragenyx Pharmaceutical Business Overview Table 75. Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Product Portfolio Table 77. Ultragenyx Pharmaceutical Recent Development Table 78. Spyre Therapeutics Company Information Table 79. Spyre Therapeutics Business Overview Table 80. Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio Table 82. Spyre Therapeutics Recent Development Table 83. Sigmapharm Laboratories Company Information Table 84. Sigmapharm Laboratories Business Overview Table 85. Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Product Portfolio Table 87. Sigmapharm Laboratories Recent Development Table 88. Selecta Biosciences Company Information Table 89. Selecta Biosciences Business Overview Table 90. Selecta Biosciences Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Selecta Biosciences Acute Hyperammonemia Treatment Drugs Product Portfolio Table 92. Selecta Biosciences Recent Development Table 93. Recordati Company Information Table 94. Recordati Business Overview Table 95. Recordati Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Recordati Acute Hyperammonemia Treatment Drugs Product Portfolio Table 97. Recordati Recent Development Table 98. Orpharma Company Information Table 99. Orpharma Business Overview Table 100. Orpharma Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Orpharma Acute Hyperammonemia Treatment Drugs Product Portfolio Table 102. Orpharma Recent Development Table 103. Medunik Company Information Table 104. Medunik Business Overview Table 105. Medunik Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Medunik Acute Hyperammonemia Treatment Drugs Product Portfolio Table 107. Medunik Recent Development Table 108. Immedica Company Information Table 109. Immedica Business Overview Table 110. Immedica Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Immedica Acute Hyperammonemia Treatment Drugs Product Portfolio Table 112. Immedica Recent Development Table 113. Arcturus Therapeutics Company Information Table 114. Arcturus Therapeutics Business Overview Table 115. Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio Table 117. Arcturus Therapeutics Recent Development Table 118. Acer Therapeutics Company Information Table 119. Acer Therapeutics Business Overview Table 120. Acer Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Acer Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio Table 122. Acer Therapeutics Recent Development Table 123. North America Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 126. North America Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 127. North America Acute Hyperammonemia Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Acute Hyperammonemia Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 132. North America Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 133. North America Acute Hyperammonemia Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Acute Hyperammonemia Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Acute Hyperammonemia Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 140. North America Acute Hyperammonemia Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 141. North America Acute Hyperammonemia Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Acute Hyperammonemia Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 144. Canada Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 145. Mexico Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 146. Europe Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 149. Europe Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 150. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 155. Europe Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 156. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Europe Acute Hyperammonemia Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 163. Europe Acute Hyperammonemia Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 164. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Acute Hyperammonemia Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 167. France Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 168. U.K. Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 169. Italy Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 170. Russia Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 171. Spain Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 174. Sweden Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 175. Poland Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 176. China Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 177. China Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 178. China Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 179. China Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 180. China Acute Hyperammonemia Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 181. China Acute Hyperammonemia Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 182. China Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 183. China Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 184. China Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 185. China Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 186. China Acute Hyperammonemia Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 187. China Acute Hyperammonemia Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 191. Asia Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 192. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Asia Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 197. Asia Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 198. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. Asia Acute Hyperammonemia Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 205. Asia Acute Hyperammonemia Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 206. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Asia Acute Hyperammonemia Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Japan Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 209. South Korea Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 210. India Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 211. Australia Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 217. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 218. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 219. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 220. SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 223. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 224. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 225. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 226. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 231. SAMEA Acute Hyperammonemia Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 232. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 233. SAMEA Acute Hyperammonemia Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Brazil Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 235. Argentina Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 236. Chile Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 237. Colombia Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 238. Peru Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 240. Israel Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 241. UAE Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 242. Turkey Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 243. Iran Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 244. Egypt Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Acute Hyperammonemia Treatment Drugs Distributors List Table 248. Acute Hyperammonemia Treatment Drugs Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Acute Hyperammonemia Treatment Drugs Image Figure 2. Global Acute Hyperammonemia Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acute Hyperammonemia Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sodium Phenylbutyrate Image Figure 5. Sodium Benzoate Image Figure 6. Arginine Image Figure 7. Other Image Figure 8. Global Acute Hyperammonemia Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Acute Hyperammonemia Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Acute Hyperammonemia Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Acute Hyperammonemia Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Acute Hyperammonemia Treatment Drugs Sales (2021-2032) & (K Units) Figure 18. Global Acute Hyperammonemia Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Acute Hyperammonemia Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Acute Hyperammonemia Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Acute Hyperammonemia Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Acute Hyperammonemia Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Acute Hyperammonemia Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Acute Hyperammonemia Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Acute Hyperammonemia Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Acute Hyperammonemia Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Acute Hyperammonemia Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Acute Hyperammonemia Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Acute Hyperammonemia Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Acute Hyperammonemia Treatment Drugs Revenue Share by Type (2021-2032) Figure 41. North America Acute Hyperammonemia Treatment Drugs Sales Share by Type (2021-2032) Figure 42. North America Acute Hyperammonemia Treatment Drugs Revenue Share by Application (2021-2032) Figure 43. North America Acute Hyperammonemia Treatment Drugs Sales Share by Application (2021-2032) Figure 44. North America Acute Hyperammonemia Treatment Drugs Revenue Share by Country (2021-2032) Figure 45. North America Acute Hyperammonemia Treatment Drugs Sales Share by Country (2021-2032) Figure 46. Europe Acute Hyperammonemia Treatment Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Acute Hyperammonemia Treatment Drugs Sales Share by Type (2021-2032) Figure 48. Europe Acute Hyperammonemia Treatment Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Acute Hyperammonemia Treatment Drugs Sales Share by Application (2021-2032) Figure 50. Europe Acute Hyperammonemia Treatment Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Acute Hyperammonemia Treatment Drugs Sales Share by Country (2021-2032) Figure 52. China Acute Hyperammonemia Treatment Drugs Revenue Share by Type (2021-2032) Figure 53. China Acute Hyperammonemia Treatment Drugs Sales Share by Type (2021-2032) Figure 54. China Acute Hyperammonemia Treatment Drugs Revenue Share by Application (2021-2032) Figure 55. China Acute Hyperammonemia Treatment Drugs Sales Share by Application (2021-2032) Figure 56. Asia Acute Hyperammonemia Treatment Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Acute Hyperammonemia Treatment Drugs Sales Share by Type (2021-2032) Figure 58. Asia Acute Hyperammonemia Treatment Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Acute Hyperammonemia Treatment Drugs Sales Share by Application (2021-2032) Figure 60. Asia Acute Hyperammonemia Treatment Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Acute Hyperammonemia Treatment Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Acute Hyperammonemia Treatment Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Acute Hyperammonemia Treatment Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Acute Hyperammonemia Treatment Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Acute Hyperammonemia Treatment Drugs Sales Share by Country (2021-2032) Figure 68. Acute Hyperammonemia Treatment Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Acute Hyperammonemia Treatment Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Phenylbutyrate
  • Sodium Benzoate
  • Arginine
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott Laboratories
  • Lee's Pharmaceutical
  • Amgen
  • Ultragenyx Pharmaceutical
  • Spyre Therapeutics
  • Sigmapharm Laboratories
  • Selecta Biosciences
  • Recordati
  • Orpharma
  • Medunik
  • Immedica
  • Arcturus Therapeutics
  • Acer Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acute Hyperammonemia Treatment Drugs Market by Type
  3. 1.2.1 Global Acute Hyperammonemia Treatment Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sodium Phenylbutyrate
  5. 1.2.3 Sodium Benzoate
  6. 1.2.4 Arginine
  7. 1.2.5 Other
  8. 1.3 Acute Hyperammonemia Treatment Drugs Market by Application
  9. 1.3.1 Global Acute Hyperammonemia Treatment Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Acute Hyperammonemia Treatment Drugs Market Dynamics
  1. 2.1 Acute Hyperammonemia Treatment Drugs Industry Trends
  2. 2.2 Acute Hyperammonemia Treatment Drugs Industry Drivers
  3. 2.3 Acute Hyperammonemia Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Acute Hyperammonemia Treatment Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Acute Hyperammonemia Treatment Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Acute Hyperammonemia Treatment Drugs Revenue by Region
  3. 3.2.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acute Hyperammonemia Treatment Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Acute Hyperammonemia Treatment Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Acute Hyperammonemia Treatment Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Acute Hyperammonemia Treatment Drugs Sales by Region
  9. 3.4.1 Global Acute Hyperammonemia Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Acute Hyperammonemia Treatment Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Acute Hyperammonemia Treatment Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Manufacturers
  2. 4.1.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Acute Hyperammonemia Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acute Hyperammonemia Treatment Drugs Sales by Manufacturers
  6. 4.2.1 Global Acute Hyperammonemia Treatment Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Acute Hyperammonemia Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Acute Hyperammonemia Treatment Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Acute Hyperammonemia Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Acute Hyperammonemia Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Acute Hyperammonemia Treatment Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Acute Hyperammonemia Treatment Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Acute Hyperammonemia Treatment Drugs Market CR5 and HHI
  16. 4.8.2 2025 Acute Hyperammonemia Treatment Drugs Tier 1, Tier 2, and Tier 3
5 Acute Hyperammonemia Treatment Drugs Market by Type
  1. 5.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Type
  2. 5.1.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Acute Hyperammonemia Treatment Drugs Sales by Type
  6. 5.2.1 Global Acute Hyperammonemia Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Acute Hyperammonemia Treatment Drugs Price by Type
6 Acute Hyperammonemia Treatment Drugs Market by Application
  1. 6.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Application
  2. 6.1.1 Global Acute Hyperammonemia Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Acute Hyperammonemia Treatment Drugs Sales by Application
  6. 6.2.1 Global Acute Hyperammonemia Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Acute Hyperammonemia Treatment Drugs Price by Application
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Acute Hyperammonemia Treatment Drugs Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Lee's Pharmaceutical
  8. 7.2.1 Lee's Pharmaceutical Company Information
  9. 7.2.2 Lee's Pharmaceutical Business Overview
  10. 7.2.3 Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Product Portfolio
  12. 7.2.5 Lee's Pharmaceutical Recent Developments
  13. 7.3 Amgen
  14. 7.3.1 Amgen Company Information
  15. 7.3.2 Amgen Business Overview
  16. 7.3.3 Amgen Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Acute Hyperammonemia Treatment Drugs Product Portfolio
  18. 7.3.5 Amgen Recent Developments
  19. 7.4 Ultragenyx Pharmaceutical
  20. 7.4.1 Ultragenyx Pharmaceutical Company Information
  21. 7.4.2 Ultragenyx Pharmaceutical Business Overview
  22. 7.4.3 Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Product Portfolio
  24. 7.4.5 Ultragenyx Pharmaceutical Recent Developments
  25. 7.5 Spyre Therapeutics
  26. 7.5.1 Spyre Therapeutics Company Information
  27. 7.5.2 Spyre Therapeutics Business Overview
  28. 7.5.3 Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio
  30. 7.5.5 Spyre Therapeutics Recent Developments
  31. 7.6 Sigmapharm Laboratories
  32. 7.6.1 Sigmapharm Laboratories Company Information
  33. 7.6.2 Sigmapharm Laboratories Business Overview
  34. 7.6.3 Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Product Portfolio
  36. 7.6.5 Sigmapharm Laboratories Recent Developments
  37. 7.7 Selecta Biosciences
  38. 7.7.1 Selecta Biosciences Company Information
  39. 7.7.2 Selecta Biosciences Business Overview
  40. 7.7.3 Selecta Biosciences Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Selecta Biosciences Acute Hyperammonemia Treatment Drugs Product Portfolio
  42. 7.7.5 Selecta Biosciences Recent Developments
  43. 7.8 Recordati
  44. 7.8.1 Recordati Company Information
  45. 7.8.2 Recordati Business Overview
  46. 7.8.3 Recordati Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Recordati Acute Hyperammonemia Treatment Drugs Product Portfolio
  48. 7.8.5 Recordati Recent Developments
  49. 7.9 Orpharma
  50. 7.9.1 Orpharma Company Information
  51. 7.9.2 Orpharma Business Overview
  52. 7.9.3 Orpharma Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Orpharma Acute Hyperammonemia Treatment Drugs Product Portfolio
  54. 7.9.5 Orpharma Recent Developments
  55. 7.10 Medunik
  56. 7.10.1 Medunik Company Information
  57. 7.10.2 Medunik Business Overview
  58. 7.10.3 Medunik Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Medunik Acute Hyperammonemia Treatment Drugs Product Portfolio
  60. 7.10.5 Medunik Recent Developments
  61. 7.11 Immedica
  62. 7.11.1 Immedica Company Information
  63. 7.11.2 Immedica Business Overview
  64. 7.11.3 Immedica Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Immedica Acute Hyperammonemia Treatment Drugs Product Portfolio
  66. 7.11.5 Immedica Recent Developments
  67. 7.12 Arcturus Therapeutics
  68. 7.12.1 Arcturus Therapeutics Company Information
  69. 7.12.2 Arcturus Therapeutics Business Overview
  70. 7.12.3 Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio
  72. 7.12.5 Arcturus Therapeutics Recent Developments
  73. 7.13 Acer Therapeutics
  74. 7.13.1 Acer Therapeutics Company Information
  75. 7.13.2 Acer Therapeutics Business Overview
  76. 7.13.3 Acer Therapeutics Acute Hyperammonemia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Acer Therapeutics Acute Hyperammonemia Treatment Drugs Product Portfolio
  78. 7.13.5 Acer Therapeutics Recent Developments
8 North America
  1. 8.1 North America Acute Hyperammonemia Treatment Drugs Market Size by Type
  2. 8.1.1 North America Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Acute Hyperammonemia Treatment Drugs Price by Type (2021-2032)
  5. 8.2 North America Acute Hyperammonemia Treatment Drugs Market Size by Application
  6. 8.2.1 North America Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Acute Hyperammonemia Treatment Drugs Price by Application (2021-2032)
  9. 8.3 North America Acute Hyperammonemia Treatment Drugs Market Size by Country
  10. 8.3.1 North America Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Acute Hyperammonemia Treatment Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Acute Hyperammonemia Treatment Drugs Market Size by Type
  2. 9.1.1 Europe Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Acute Hyperammonemia Treatment Drugs Price by Type (2021-2032)
  5. 9.2 Europe Acute Hyperammonemia Treatment Drugs Market Size by Application
  6. 9.2.1 Europe Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Acute Hyperammonemia Treatment Drugs Price by Application (2021-2032)
  9. 9.3 Europe Acute Hyperammonemia Treatment Drugs Market Size by Country
  10. 9.3.1 Europe Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Acute Hyperammonemia Treatment Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Acute Hyperammonemia Treatment Drugs Market Size by Type
  2. 10.1.1 China Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Acute Hyperammonemia Treatment Drugs Price by Type (2021-2032)
  5. 10.2 China Acute Hyperammonemia Treatment Drugs Market Size by Application
  6. 10.2.1 China Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Acute Hyperammonemia Treatment Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acute Hyperammonemia Treatment Drugs Market Size by Type
  2. 11.1.1 Asia Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Acute Hyperammonemia Treatment Drugs Price by Type (2021-2032)
  5. 11.2 Asia Acute Hyperammonemia Treatment Drugs Market Size by Application
  6. 11.2.1 Asia Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Acute Hyperammonemia Treatment Drugs Price by Application (2021-2032)
  9. 11.3 Asia Acute Hyperammonemia Treatment Drugs Market Size by Country
  10. 11.3.1 Asia Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Acute Hyperammonemia Treatment Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acute Hyperammonemia Treatment Drugs Market Size by Type
  2. 12.1.1 SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Acute Hyperammonemia Treatment Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Acute Hyperammonemia Treatment Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Acute Hyperammonemia Treatment Drugs Market Size by Application
  6. 12.2.1 SAMEA Acute Hyperammonemia Treatment Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Acute Hyperammonemia Treatment Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Acute Hyperammonemia Treatment Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Acute Hyperammonemia Treatment Drugs Market Size by Country
  10. 12.3.1 SAMEA Acute Hyperammonemia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Acute Hyperammonemia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Acute Hyperammonemia Treatment Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Acute Hyperammonemia Treatment Drugs Value Chain Analysis
  2. 13.1.1 Acute Hyperammonemia Treatment Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Acute Hyperammonemia Treatment Drugs Production Mode & Process
  6. 13.2 Acute Hyperammonemia Treatment Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Acute Hyperammonemia Treatment Drugs Distributors
  9. 13.2.3 Acute Hyperammonemia Treatment Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst